High-intensity interval training recuperates capacity of endogenous thrombin generation in heart failure patients with reduced ejection fraction

被引:3
|
作者
Hsu, Chih-Chin [1 ]
Fu, Tieh-Cheng [1 ]
Huang, Shu-Chun [2 ]
Wang, Jong-Shyan [1 ,3 ,4 ]
机构
[1] Chang Gung Mem Hosp, Heart Failure Ctr, Dept Phys Med & Rehabil, Keelung, Taiwan
[2] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan
[3] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Hlth Aging Res Ctr, Taoyuan, Taiwan
[4] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan
关键词
Heart failure; Exercise; Microparticles; Thrombin; OXYGEN-UPTAKE EFFICIENCY; DISSEMINATED INTRAVASCULAR COAGULATION; LEFT-VENTRICULAR THROMBUS; PROCOAGULANT MICROPARTICLES; EXERCISE REGIMENS; COAGULOPATHY; SLOPE;
D O I
10.1016/j.thromres.2020.01.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Consumptive coagulopathy is associated with increased mortality in patients with heart failure (HF). Physical activity influences the risk of major vascular thrombotic events. This study investigates how high-intensity interval training (HIIT) affects the capacity of endogenous thrombin generation (TG) by modulating circulatory procoagulant microparticles (MPs) in HF patients. Methods: Thirty-eight HF patients with reduced ejection fraction (HFrEF) and 38 age- and gender-matched normal counterparts (NC) were recruited into this study. The HFrEF group performed HIIT (3-min intervals at 40% and 80%VO2peak) on a bicycle ergometer for 30 min/day, 3 days/week for 12 weeks, whereas the NC group did not receive any form of intervention. Plasma TG kinetics, procoagulant MPs, coagulation-related factors, and oxidative stress/proinflammatory status were analyzed. Results: The HFrEF group exhibited (i) less endogenous thrombin potential (ETP) and TG rate, (ii) lower concentration/activity of tissue factor (TF) and counts of TF-rich MPs derived from blood cells, and (iii) higher vascular endothelial shedding and plasma myeloperoxidase and interleukin-6 concentrations, compared to the NC group did. However, HIIT elevated TG rate and TF concentration/activity in plasma, as well as, TF-rich MP counts derived from blood cells in patients with HFrEF. Moreover, the exercise regimen also decreased vascular endothelial shedding and plasma myeloperoxidase and interleukin-6 concentrations in HFrEF patients. Conclusion: HFrEF reduces the capacity of endogenous TG in plasma, which is associated with decreased (or consumed) circulatory procoagulant MP levels. However, HIIT alleviates HFrEF-declined endogenous TG capacity and vascular endothelial damage through recuperating TF-related coagulation activity and suppressing oxidative stress/proinflammatory status.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 50 条
  • [41] Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    Armstrong, Paul W.
    Pieske, Burkert
    Anstrom, Kevin J.
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Jia, Gang
    McNulty, Steven E.
    Patel, Mahesh J.
    Roessig, Lothar
    Koglin, Joerg
    O'Connor, Christopher M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20): : 1883 - 1893
  • [42] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [43] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [44] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [45] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Volpe, Massimo
    Santolamazza, Caterina
    Tocci, Giuliano
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [46] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [47] Cells in Patients with Heart Failure with Reduced Ejection Fraction
    Lopes, Jose
    Teixeira, Manuel
    Cavalcante, Suiane
    Gouveia, Marisol
    Duarte, Ana
    Ferreira, Miriam
    Simoes, Maria I.
    Conceicao, Maria
    Ribeiro, Ilda P.
    Goncalves, Ana C.
    Schmidt, Cristine
    de Jesus, Bruno Bernardes
    Almeida, Ramiro
    Viamonte, Sofia
    Santos, Mario
    Ribeiro, Fernando
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (03) : 289 - 295
  • [48] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Massimo Volpe
    Caterina Santolamazza
    Giuliano Tocci
    Current Cardiology Reports, 2016, 18
  • [49] Benzodiazepines in Patients with Heart Failure and Reduced Ejection Fraction
    Chuang, Chi
    Hsiao, Fu-Chih
    Cheng, Yu-Wen
    Lin, Chia-Pin
    Tung, Ying-Chang
    Wu, Chia-Tung
    Chen, Ching-Yen
    Chu, Pao-Hsien
    ACTA CARDIOLOGICA SINICA, 2022, 38 (05) : 573 - 583
  • [50] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Borghi, Claudio
    Cicero, Arrigo F. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 972